BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, September 12, 2024
See today's BioWorld Asia
Home
» Other news to note for April 26, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for April 26, 2022
April 26, 2022
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Arrowhead, Ascletis, Astellas, Beijing Xuansheng, Biocytogen, Biogen, Bridge, Celsion, Codiak, Comera, Ctm, Finch, Gilead Sciences, Hainan Sihuan, Immvira, Intas, Janssen, Legend Biotech USA, Pfizer, Roche, Samsung, Selva, Shaperon, Sihuan, Takeda, Tonix, Visirna.
BioWorld Asia
Briefs
Other news to note